The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype
10.1007/s00401-014-1251-9
Crossref journal-article
Springer Science and Business Media LLC
Acta Neuropathologica (297)
Bibliography

Cooper-Knock, J., Shaw, P. J., & Kirby, J. (2014). The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype. Acta Neuropathologica, 127(3), 333–345.

Authors 3
  1. Johnathan Cooper-Knock (first)
  2. Pamela J. Shaw (additional)
  3. Janine Kirby (additional)
References 96 Referenced 138
  1. Beck J, Poulter M, Hensman D, Rohrer JD, Mahoney CJ, Adamson G, Campbell T, Uphill J, Borg A, Fratta P, Orrell RW, Malaspina A, Rowe J, Brown J, Hodges J et al (2013) Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population. Am J Hum Genet 92(3):345–353. doi: 10.1016/j.ajhg.2013.01.011 (10.1016/j.ajhg.2013.01.011) / Am J Hum Genet by J Beck (2013)
  2. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, Kouri N, Wojtas A, Sengdy P, Hsiung GY, Karydas A et al (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72(2):245–256. doi: 10.1016/j.neuron.2011.09.011 (10.1016/j.neuron.2011.09.011) / Neuron by M DeJesus-Hernandez (2011)
  3. Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L, Kalimo H, Paetau A, Abramzon Y, Remes AM, Kaganovich A et al (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72(2):257–268. doi: 10.1016/j.neuron.2011.09.010 (10.1016/j.neuron.2011.09.010) / Neuron by AE Renton (2011)
  4. Cooper-Knock J, Hewitt C, Highley JR, Brockington A, Milano A, Man S, Martindale J, Hartley J, Walsh T, Gelsthorpe C, Baxter L, Forster G, Fox M, Bury J, Mok K et al (2012) Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain 135(Pt 3):751–764. doi: 10.1093/brain/awr365 (10.1093/brain/awr365) / Brain by J Cooper-Knock (2012)
  5. Majounie E, Renton AE, Mok K, Dopper EG, Waite A, Rollinson S, Chio A, Restagno G, Nicolaou N, Simon-Sanchez J, van Swieten JC, Abramzon Y, Johnson JO, Sendtner M, Pamphlett R et al (2012) Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol 11(4):323–330. doi: 10.1016/S1474-4422(12)70043-1 (10.1016/S1474-4422(12)70043-1) / Lancet Neurol by E Majounie (2012)
  6. Benussi L, Rossi G, Glionna M, Tonoli E, Piccoli E, Fostinelli S, Paterlini A, Flocco R, Albani D, Pantieri R, Cereda C, Forloni G, Tagliavini F, Binetti G, Ghidoni R (2013) C9ORF72 Hexanucleotide Repeat Number in Frontotemporal Lobar Degeneration: a Genotype-Phenotype Correlation Study. J Alzheimers Dis. doi: 10.3233/JAD-131028 / J Alzheimers Dis by L Benussi (2013)
  7. Galimberti D, Arosio B, Fenoglio C, Serpente M, Cioffi SM, Bonsi R, Rossi P, Abbate C, Mari D, Scarpini E (2013) Incomplete Penetrance of the C9ORF72 Hexanucleotide Repeat Expansions: frequency in a Cohort of Geriatric Non-Demented Subjects. J Alzheimers Dis. doi: 10.3233/JAD-131172 / J Alzheimers Dis by D Galimberti (2013)
  8. Johnston CA, Stanton BR, Turner MR, Gray R, Blunt AH, Butt D, Ampong MA, Shaw CE, Leigh PN, Al-Chalabi A (2006) Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London. J Neurol 253(12):1642–1643. doi: 10.1007/s00415-006-0195-y (10.1007/s00415-006-0195-y) / J Neurol by CA Johnston (2006)
  9. Mercy L, Hodges JR, Dawson K, Barker RA, Brayne C (2008) Incidence of early-onset dementias in Cambridgeshire, United Kingdom. Neurology 71(19):1496–1499. doi: 10.1212/01.wnl.0000334277.16896.fa (10.1212/01.wnl.0000334277.16896.fa) / Neurology by L Mercy (2008)
  10. van Blitterswijk M, van Es MA, Hennekam EA, Dooijes D, van Rheenen W, Medic J, Bourque PR, Schelhaas HJ, van der Kooi AJ, de Visser M, de Bakker PI, Veldink JH, van den Berg LH (2012) Evidence for an oligogenic basis of amyotrophic lateral sclerosis. Hum Mol Genet 21(17):3776–3784. doi: 10.1093/hmg/dds199 (10.1093/hmg/dds199) / Hum Mol Genet by M Blitterswijk van (2012)
  11. Ferrari R, Mok K, Moreno JH, Cosentino S, Goldman J, Pietrini P, Mayeux R, Tierney MC, Kapogiannis D, Jicha GA, Murrell JR, Ghetti B, Wassermann EM, Grafman J, Hardy J et al (2012) Screening for C9ORF72 repeat expansion in FTLD. Neurobiol Aging 33(8):1850.e1–1850.e11. doi: 10.1016/j.neurobiolaging.2012.02.017 (10.1016/j.neurobiolaging.2012.02.017) / Neurobiol Aging by R Ferrari (2012)
  12. Lashley T, Rohrer JD, Mahoney C, Gordon E, Beck J, Mead S, Warren J, Rossor M, Revesz T (2013) A pathogenic progranulin mutation and C9orf72 repeat expansion in a family with frontotemporal dementia. Neuropathol Appl Neurobiol. doi: 10.1111/nan.12100 / Neuropathol Appl Neurobiol by T Lashley (2013)
  13. Byrne S, Walsh C, Lynch C, Bede P, Elamin M, Kenna K, McLaughlin R, Hardiman O (2011) Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 82(6):623–627. doi: 10.1136/jnnp.2010.224501 (10.1136/jnnp.2010.224501) / J Neurol Neurosurg Psychiatry by S Byrne (2011)
  14. Al-Chalabi A, Fang F, Hanby MF, Leigh PN, Shaw CE, Ye W, Rijsdijk F (2010) An estimate of amyotrophic lateral sclerosis heritability using twin data. J Neurol Neurosurg Psychiatry 81(12):1324–1326. doi: 10.1136/jnnp.2010.207464 (10.1136/jnnp.2010.207464) / J Neurol Neurosurg Psychiatry by A Al-Chalabi (2010)
  15. Goodall EF, Bury JJ, Cooper-Knock J, Shaw PJ, Kirby J (2012) Genetics of familial amyotrophic lateral sclerosis. In: Maurer MH (ed) Amyotrophic lateral sclerosis. Intech, Rijeka, pp 517–536 / Amyotrophic lateral sclerosis by EF Goodall (2012)
  16. Konno T, Shiga A, Tsujino A, Sugai A, Kato T, Kanai K, Yokoseki A, Eguchi H, Kuwabara S, Nishizawa M, Takahashi H, Onodera O (2013) Japanese amyotrophic lateral sclerosis patients with GGGGCC hexanucleotide repeat expansion in C9ORF72. J Neurol Neurosurg Psychiatry 84(4):398–401. doi: 10.1136/jnnp-2012-302272 (10.1136/jnnp-2012-302272) / J Neurol Neurosurg Psychiatry by T Konno (2013)
  17. Shatunov A, Mok K, Newhouse S, Weale ME, Smith B, Vance C, Johnson L, Veldink JH, van Es MA, van den Berg LH, Robberecht W, Van Damme P, Hardiman O, Farmer AE, Lewis CM et al (2010) Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study. Lancet Neurol 9(10):986–994. doi: 10.1016/S1474-4422(10)70197-6 (10.1016/S1474-4422(10)70197-6) / Lancet Neurol by A Shatunov (2010)
  18. Mok K, Traynor BJ, Schymick J, Tienari PJ, Laaksovirta H, Peuralinna T, Myllykangas L, Chiò A, Shatunov A, Boeve BF, Boxer AL, DeJesus-Hernandez M, Mackenzie IR, Waite A, Williams N et al (2012) Chromosome 9 ALS and FTD locus is probably derived from a single founder. Neurobiol Aging 33(1):209.e3–209.e8. doi: 10.1016/j.neurobiolaging.2011.08.005 (10.1016/j.neurobiolaging.2011.08.005) / Neurobiol Aging by K Mok (2012)
  19. Smith BN, Newhouse S, Shatunov A, Vance C, Topp S, Johnson L, Miller J, Lee Y, Troakes C, Scott KM, Jones A, Gray I, Wright J, Hortobagyi T, Al-Sarraj S et al (2013) The C9ORF72 expansion mutation is a common cause of ALS ± FTD in Europe and has a single founder. Eur J Hum Genet 21(1):102–108. doi: 10.1038/ejhg.2012.98 (10.1038/ejhg.2012.98) / Eur J Hum Genet by BN Smith (2013)
  20. Dobson-Stone C, Hallupp M, Bartley L, Shepherd CE, Halliday GM, Schofield PR, Hodges JR, Kwok JB (2012) C9ORF72 repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts. Neurology 79(10):995–1001. doi: 10.1212/WNL.0b013e3182684634 (10.1212/WNL.0b013e3182684634) / Neurology by C Dobson-Stone (2012)
  21. del Aguila MA, Longstreth WT Jr, McGuire V, Koepsell TD, van Belle G (2003) Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 60(5):813–819 (10.1212/01.WNL.0000049472.47709.3B) / Neurology by MA Aguila del (2003)
  22. McDermott CJ, Shaw PJ (2008) Diagnosis and management of motor neurone disease. BMJ 336(7645):658–662. doi: 10.1136/bmj.39493.511759.BE (10.1136/bmj.39493.511759.BE) / BMJ by CJ McDermott (2008)
  23. Preux PM, Couratier P, Boutros-Toni F, Salle JY, Tabaraud F, Bernet-Bernady P, Vallat JM, Dumas M (1996) Survival prediction in sporadic amyotrophic lateral sclerosis. Age and clinical form at onset are independent risk factors. Neuroepidemiology 15(3):153–160 (10.1159/000109902) / Neuroepidemiology by PM Preux (1996)
  24. Cooper-Knock J, Jenkins T, Shaw PJ (2013) Clinical and Molecular Aspects of Motor Neuron Disease. Colloq Ser Genomic Mol Med 2(2):1–60 (10.4199/C00093ED1V01Y201309GMM004) / Colloq Ser Genomic Mol Med by J Cooper-Knock (2013)
  25. Gijselinck I, Van Langenhove T, van der Zee J, Sleegers K, Philtjens S, Kleinberger G, Janssens J, Bettens K, Van Cauwenberghe C, Pereson S, Engelborghs S, Sieben A, De Jonghe P, Vandenberghe R, Santens P et al (2012) A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol 11(1):54–65. doi: 10.1016/S1474-4422(11)70261-7 (10.1016/S1474-4422(11)70261-7) / Lancet Neurol by I Gijselinck (2012)
  26. Murray ME, DeJesus-Hernandez M, Rutherford NJ, Baker M, Duara R, Graff-Radford NR, Wszolek ZK, Ferman TJ, Josephs KA, Boylan KB, Rademakers R, Dickson DW (2011) Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72. Acta Neuropathol 122(6):673–690. doi: 10.1007/s00401-011-0907-y (10.1007/s00401-011-0907-y) / Acta Neuropathol by ME Murray (2011)
  27. Debray S, Race V, Crabbé V, Herdewyn S, Matthijs G, Goris A, Dubois B, Thijs V, Robberecht W, Van Damme P (2013) Frequency of C9orf72 repeat expansions in amyotrophic lateral sclerosis: a Belgian cohort study. Neurobiol Aging 34(12):2890.e7–2890.e12. doi: 10.1016/j.neurobiolaging.2013.06.009 (10.1016/j.neurobiolaging.2013.06.009) / Neurobiol Aging by S Debray (2013)
  28. Ratti A, Corrado L, Castellotti B, Del Bo R, Fogh I, Cereda C, Tiloca C, D’Ascenzo C, Bagarotti A, Pensato V, Ranieri M, Gagliardi S, Calini D, Mazzini L, Taroni F et al (2012) C9ORF72 repeat expansion in a large Italian ALS cohort: evidence of a founder effect. Neurobiol Aging 33(10):2528.e7–2528.e14. doi: 10.1016/j.neurobiolaging.2012.06.008 (10.1016/j.neurobiolaging.2012.06.008) / Neurobiol Aging by A Ratti (2012)
  29. Stewart H, Rutherford NJ, Briemberg H, Krieger C, Cashman N, Fabros M, Baker M, Fok A, DeJesus-Hernandez M, Eisen A, Rademakers R, Mackenzie IR (2012) Clinical and pathological features of amyotrophic lateral sclerosis caused by mutation in the C9ORF72 gene on chromosome 9p. Acta Neuropathol 123(3):409–417. doi: 10.1007/s00401-011-0937-5 (10.1007/s00401-011-0937-5) / Acta Neuropathol by H Stewart (2012)
  30. Byrne S, Elamin M, Bede P, Shatunov A, Walsh C, Corr B, Heverin M, Jordan N, Kenna K, Lynch C, McLaughlin RL, Iyer PM, O’Brien C, Phukan J, Wynne B et al (2012) Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study. Lancet Neurol 11(3):232–240. doi: 10.1016/S1474-4422(12)70014-5 (10.1016/S1474-4422(12)70014-5) / Lancet Neurol by S Byrne (2012)
  31. Garcia-Redondo A, Dols-Icardo O, Rojas-Garcia R, Esteban-Perez J, Cordero-Vazquez P, Munoz-Blanco JL, Catalina I, Gonzalez-Munoz M, Varona L, Sarasola E, Povedano M, Sevilla T, Guerrero A, Pardo J, Lopez de Munain A et al (2013) Analysis of the C9orf72 gene in patients with amyotrophic lateral sclerosis in Spain and different populations worldwide. Hum Mutat 34(1):79–82. doi: 10.1002/humu.22211 (10.1002/humu.22211) / Hum Mutat by A Garcia-Redondo (2013)
  32. Sabatelli M, Conforti FL, Zollino M, Mora G, Monsurrò MR, Volanti P, Marinou K, Salvi F, Corbo M, Giannini F, Battistini S, Penco S, Lunetta C, Quattrone A, Gambardella A et al (2012) C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population. Neurobiol Aging 33(8):1848.e15–1848.e20. doi: 10.1016/j.neurobiolaging.2012.02.011 (10.1016/j.neurobiolaging.2012.02.011) / Neurobiol Aging by M Sabatelli (2012)
  33. Williams KL, Fifita JA, Vucic S, Durnall JC, Kiernan MC, Blair IP, Nicholson GA (2013) Pathophysiological insights into ALS with C9ORF72 expansions. J Neurol Neurosurg Psychiatry 84(8):931–935. doi: 10.1136/jnnp-2012-304529 (10.1136/jnnp-2012-304529) / J Neurol Neurosurg Psychiatry by KL Williams (2013)
  34. Millecamps S, Boillee S, Le Ber I, Seilhean D, Teyssou E, Giraudeau M, Moigneu C, Vandenberghe N, Danel-Brunaud V, Corcia P, Pradat PF, Le Forestier N, Lacomblez L, Bruneteau G, Camu W et al (2012) Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes. J Med Genet 49(4):258–263. doi: 10.1136/jmedgenet-2011-100699 (10.1136/jmedgenet-2011-100699) / J Med Genet by S Millecamps (2012)
  35. Boeve BF, Boylan KB, Graff-Radford NR, DeJesus-Hernandez M, Knopman DS, Pedraza O, Vemuri P, Jones D, Lowe V, Murray ME, Dickson DW, Josephs KA, Rush BK, Machulda MM, Fields JA et al (2012) Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain 135(Pt 3):765–783. doi: 10.1093/brain/aws004 (10.1093/brain/aws004) / Brain by BF Boeve (2012)
  36. O’Dowd S, Curtin D, Waite AJ, Roberts K, Pender N, Reid V, O’Connell M, Williams NM, Morris HR, Traynor BJ, Lynch T (2012) C9ORF72 expansion in amyotrophic lateral sclerosis/frontotemporal dementia also causes parkinsonism. Mov Disord 27(8):1072–1074. doi: 10.1002/mds.25022 (10.1002/mds.25022) / Mov Disord by S O’Dowd (2012)
  37. Akimoto C, Forsgren L, Linder J, Birve A, Backlund I, Andersson J, Nilsson AC, Alstermark H, Andersen PM (2013) No GGGGCC-hexanucleotide repeat expansion in C9ORF72 in parkinsonism patients in Sweden. Amyotroph Lateral Scler Frontotemporal Degener 14(1):26–29. doi: 10.3109/17482968.2012.725415 (10.3109/17482968.2012.725415) / Amyotroph Lateral Scler Frontotemporal Degener by C Akimoto (2013)
  38. Harms MB, Neumann D, Benitez BA, Cooper B, Carrell D, Racette BA, Perlmutter JS, Goate A, Cruchaga C (2013) Parkinson disease is not associated with C9ORF72 repeat expansions. Neurobiol Aging 34(5):1519.e1–1519.e12. doi: 10.1016/j.neurobiolaging.2012.10.001 (10.1016/j.neurobiolaging.2012.10.001) / Neurobiol Aging by MB Harms (2013)
  39. Majounie E, Abramzon Y, Renton AE, Keller MF, Traynor BJ, Singleton AB (2012) Large C9orf72 repeat expansions are not a common cause of Parkinson’s disease. Neurobiol Aging 33(10):2527.e1–2527.e2. doi: 10.1016/j.neurobiolaging.2012.05.007 (10.1016/j.neurobiolaging.2012.05.007) / Neurobiol Aging by E Majounie (2012)
  40. Cooper-Knock J, Frolov A, Highley JR, Charlesworth G, Kirby J, Milano A, Hartley J, Ince PG, McDermott CJ, Lashley T, Revesz T, Shaw PJ, Wood NW, Bandmann O (2013) C9ORF72 expansions, parkinsonism, and Parkinson disease: a clinicopathologic study. Neurology. doi: 10.1212/WNL.0b013e3182a2cc38 / Neurology by J Cooper-Knock (2013)
  41. Lesage S, Le Ber I, Condroyer C, Broussolle E, Gabelle A, Thobois S, Pasquier F, Mondon K, Dion PA, Rochefort D, Rouleau GA, Durr A, Brice A, French Parkinson’s Disease Genetics Study G (2013) C9orf72 repeat expansions are a rare genetic cause of parkinsonism. Brain 136(Pt 2):385–391. doi: 10.1093/brain/aws357 (10.1093/brain/aws357) / Brain by S Lesage (2013)
  42. Ismail A, Cooper-Knock J, Highley JR, Milano A, Kirby J, Goodall E, Lowe J, Scott I, Constantinescu CS, Walters SJ, Price S, McDermott CJ, Sawcer S, Compston DA, Sharrack B et al (2013) Concurrence of multiple sclerosis and amyotrophic lateral sclerosis in patients with hexanucleotide repeat expansions of C9ORF72. J Neurol Neurosurg Psychiatry 84(1):79–87. doi: 10.1136/jnnp-2012-303326 (10.1136/jnnp-2012-303326) / J Neurol Neurosurg Psychiatry by A Ismail (2013)
  43. van Rheenen W, van Blitterswijk M, Huisman MH, Vlam L, van Doormaal PT, Seelen M, Medic J, Dooijes D, de Visser M, van der Kooi AJ, Raaphorst J, Schelhaas HJ, van der Pol WL, Veldink JH, van den Berg LH (2012) Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases. Neurology 79(9):878–882. doi: 10.1212/WNL.0b013e3182661d14 (10.1212/WNL.0b013e3182661d14) / Neurology by W Rheenen van (2012)
  44. Rutherford NJ, DeJesus-Hernandez M, Baker MC, Kryston TB, Brown PE, Lomen-Hoerth C, Boylan K, Wszolek ZK, Rademakers R (2012) C9ORF72 hexanucleotide repeat expansions in patients with ALS from the Coriell Cell Repository. Neurology 79(5):482–483. doi: 10.1212/WNL.0b013e31826170f1 (10.1212/WNL.0b013e31826170f1) / Neurology by NJ Rutherford (2012)
  45. Nielsen TT, Svenstrup K, Duno M, Nielsen JE (2013) Hereditary spastic paraplegia is not associated with C9ORF72 repeat expansions in a Danish cohort. Spinal Cord. doi: 10.1038/sc.2013.116 / Spinal Cord by TT Nielsen (2013)
  46. Galimberti D, Fenoglio C, Serpente M, Villa C, Bonsi R, Arighi A, Fumagalli GG, Del Bo R, Bruni AC, Anfossi M, Clodomiro A, Cupidi C, Nacmias B, Sorbi S, Piaceri I et al (2013) Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation. Biol Psychiatry 74(5):384–391. doi: 10.1016/j.biopsych.2013.01.031 (10.1016/j.biopsych.2013.01.031) / Biol Psychiatry by D Galimberti (2013)
  47. Sha SJ, Takada LT, Rankin KP, Yokoyama JS, Rutherford NJ, Fong JC, Khan B, Karydas A, Baker MC, DeJesus-Hernandez M, Pribadi M, Coppola G, Geschwind DH, Rademakers R, Lee SE et al (2012) Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features. Neurology 79(10):1002–1011. doi: 10.1212/WNL.0b013e318268452e (10.1212/WNL.0b013e318268452e) / Neurology by SJ Sha (2012)
  48. Lindquist SG, Duno M, Batbayli M, Puschmann A, Braendgaard H, Mardosiene S, Svenstrup K, Pinborg LH, Vestergaard K, Hjermind LE, Stokholm J, Andersen BB, Johannsen P, Nielsen JE (2013) Corticobasal and ataxia syndromes widen the spectrum of C9ORF72 hexanucleotide expansion disease. Clin Genet 83(3):279–283. doi: 10.1111/j.1399-0004.2012.01903.x (10.1111/j.1399-0004.2012.01903.x) / Clin Genet by SG Lindquist (2013)
  49. Ticozzi N, Tiloca C, Calini D, Gagliardi S, Altieri A, Colombrita C, Cereda C, Ratti A, Pezzoli G, Borroni B, Goldwurm S, Padovani A, Silani V (2013) C9orf72 repeat expansions are restricted to the ALS-FTD spectrum. Neurobiol Aging. doi: 10.1016/j.neurobiolaging.2013.09.037 / Neurobiol Aging by N Ticozzi (2013)
  50. Mann DM, Rollinson S, Robinson A, Bennion CJ, Thompson JC, Snowden JS, Gendron T, Petrucelli L, Masuda-Suzukake M, Hasegawa M, Davidson Y, Pickering-Brown S (2013) Dipeptide repeat proteins are present in the p62 positive inclusions in patients with frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72. Acta Neuropathol Commun 1(1):68. doi: 10.1186/2051-5960-1-68 (10.1186/2051-5960-1-68) / Acta Neuropathol Commun by DM Mann (2013)
  51. Hensman Moss DJ, Poulter M, Beck J, Hehir J, Polke JM, Campbell T, Adamson G, Mudanohwo E, McColgan P, Haworth A, Wild EJ, Sweeney MG, Houlden H, Mead S, Tabrizi SJ (2013) C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies. Neurology. doi: 10.1212/WNL.0000000000000061 / Neurology by DJ Hensman Moss (2013)
  52. Liu Y, Yu JT, Sun FR, Ou JR, Qu SB, Tan L (2013) The clinical and pathological phenotypes of frontotemporal dementia with C9ORF72 mutations. J Neurol Sci 335(1–2):26–35. doi: 10.1016/j.jns.2013.09.013 (10.1016/j.jns.2013.09.013) / J Neurol Sci by Y Liu (2013)
  53. Kaivorinne AL, Bode MK, Paavola L, Tuominen H, Kallio M, Renton AE, Traynor BJ, Moilanen V, Remes AM (2013) Clinical Characteristics of C9ORF72-Linked Frontotemporal Lobar Degeneration. Dement Geriatr Cogn Dis Extra 3(1):251–262. doi: 10.1159/000351859 (10.1159/000351859) / Dement Geriatr Cogn Dis Extra by AL Kaivorinne (2013)
  54. Jiao B, Tang B, Liu X, Yan X, Zhou L, Yang Y, Wang J, Xia K, Shen L (2013) Identification of C9orf72 repeat expansions in patients with amyotrophic lateral sclerosis and frontotemporal dementia in mainland China. Neurobiol Aging. doi: 10.1016/j.neurobiolaging.2013.10.001 / Neurobiol Aging by B Jiao (2013)
  55. Jones AR, Woollacott I, Shatunov A, Cooper-Knock J, Buchman V, Sproviero W, Smith B, Scott KM, Balendra R, Abel O, McGuffin P, Ellis CM, Shaw PJ, Morrison KE, Farmer A et al (2013) Residual association at C9orf72 suggests an alternative amyotrophic lateral sclerosis-causing hexanucleotide repeat. Neurobiol Aging 34(9):2234.e17–2234.e7. doi: 10.1016/j.neurobiolaging.2013.03.003 (10.1016/j.neurobiolaging.2013.03.003) / Neurobiol Aging by AR Jones (2013)
  56. Hsiung GY, DeJesus-Hernandez M, Feldman HH, Sengdy P, Bouchard-Kerr P, Dwosh E, Butler R, Leung B, Fok A, Rutherford NJ, Baker M, Rademakers R, Mackenzie IR (2012) Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p. Brain 135(Pt 3):709–722. doi: 10.1093/brain/awr354 (10.1093/brain/awr354) / Brain by GY Hsiung (2012)
  57. Khan BK, Yokoyama JS, Takada LT, Sha SJ, Rutherford NJ, Fong JC, Karydas AM, Wu T, Ketelle RS, Baker MC, Hernandez MD, Coppola G, Geschwind DH, Rademakers R, Lee SE et al (2012) Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion. J Neurol Neurosurg Psychiatry 83(4):358–364. doi: 10.1136/jnnp-2011-301883 (10.1136/jnnp-2011-301883) / J Neurol Neurosurg Psychiatry by BK Khan (2012)
  58. Simon-Sanchez J, Dopper EG, Cohn-Hokke PE, Hukema RK, Nicolaou N, Seelaar H, de Graaf JR, de Koning I, van Schoor NM, Deeg DJ, Smits M, Raaphorst J, van den Berg LH, Schelhaas HJ, De Die-Smulders CE et al (2012) The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions. Brain 135(Pt 3):723–735. doi: 10.1093/brain/awr353 (10.1093/brain/awr353) / Brain by J Simon-Sanchez (2012)
  59. Snowden JS, Rollinson S, Thompson JC, Harris JM, Stopford CL, Richardson AM, Jones M, Gerhard A, Davidson YS, Robinson A, Gibbons L, Hu Q, DuPlessis D, Neary D, Mann DM et al (2012) Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain 135(Pt 3):693–708. doi: 10.1093/brain/awr355 (10.1093/brain/awr355) / Brain by JS Snowden (2012)
  60. Van Langenhove T, van der Zee J, Gijselinck I, Engelborghs S, Vandenberghe R, Vandenbulcke M, De Bleecker J, Sieben A, Versijpt J, Ivanoiu A, Deryck O, Willems C, Dillen L, Philtjens S, Maes G et al (2013) Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohort. JAMA Neurol 70(3):365–373. doi: 10.1001/2013.jamaneurol.181 (10.1001/2013.jamaneurol.181) / JAMA Neurol by T Langenhove Van (2013)
  61. Cerami C, Marcone A, Galimberti D, Zamboni M, Fenoglio C, Serpente M, Scarpini E, Cappa SF (2013) Novel evidence of phenotypical variability in the hexanucleotide repeat expansion in chromosome 9. J Alzheimers Dis 35(3):455–462. doi: 10.3233/JAD-122302 (10.3233/JAD-122302) / J Alzheimers Dis by C Cerami (2013)
  62. Rollinson S, Halliwell N, Young K, Callister JB, Toulson G, Gibbons L, Davidson YS, Robinson AC, Gerhard A, Richardson A, Neary D, Snowden J, Mann DM (1846) Pickering-Brown SM (2012) Analysis of the hexanucleotide repeat in C9ORF72 in Alzheimer’s disease. Neurobiol Aging 33(8):e1845–e1846. doi: 10.1016/j.neurobiolaging.2012.01.109 / Neurobiol Aging by S Rollinson (1846)
  63. Davidson YS, Robinson AC, Snowden JS, Mann DM (2013) Pathological assessments for the presence of hexanucleotide repeat expansions in C9ORF72 in Alzheimer’s disease. Acta Neuropathol Commun 1(1):50. doi: 10.1186/2051-5960-1-50 (10.1186/2051-5960-1-50) / Acta Neuropathol Commun by YS Davidson (2013)
  64. Cacace R, Van Cauwenberghe C, Bettens K, Gijselinck I, van der Zee J, Engelborghs S, Vandenbulcke M, Van Dongen J, Bäumer V, Dillen L, Mattheijssens M, Peeters K, Cruts M, Vandenberghe R, De Deyn PP et al (2013) C9orf72 G4C2 repeat expansions in Alzheimer’s disease and mild cognitive impairment. Neurobiol Aging 34(6):1712.e1–1712.e7. doi: 10.1016/j.neurobiolaging.2012.12.019 (10.1016/j.neurobiolaging.2012.12.019) / Neurobiol Aging by R Cacace (2013)
  65. Harms M, Benitez BA, Cairns N, Cooper B, Cooper P, Mayo K, Carrell D, Faber K, Williamson J, Bird T, Diaz-Arrastia R, Foroud TM, Boeve BF, Graff-Radford NR, Mayeux R et al (2013) C9orf72 hexanucleotide repeat expansions in clinical Alzheimer disease. JAMA Neurol 70(6):736–741. doi: 10.1001/2013.jamaneurol.537 (10.1001/2013.jamaneurol.537) / JAMA Neurol by M Harms (2013)
  66. Kohli MA, John-Williams K, Rajbhandary R, Naj A, Whitehead P, Hamilton K, Carney RM, Wright C, Crocco E, Gwirtzman HE, Lang R, Beecham G, Martin ER, Gilbert J, Benatar M et al (2013) Repeat expansions in the C9ORF72 gene contribute to Alzheimer’s disease in Caucasians. Neurobiol Aging 34(5):1519.e5–1519.e12. doi: 10.1016/j.neurobiolaging.2012.10.003 (10.1016/j.neurobiolaging.2012.10.003) / Neurobiol Aging by MA Kohli (2013)
  67. Wojtas A, Heggeli KA, Finch N, Baker M, Dejesus-Hernandez M, Younkin SG, Dickson DW, Graff-Radford NR, Rademakers R (2012) C9ORF72 repeat expansions and other FTD gene mutations in a clinical AD patient series from Mayo Clinic. Am J Neurodegener Dis 1(1):107–118 / Am J Neurodegener Dis by A Wojtas (2012)
  68. Snowden JS, Rollinson S, Lafon C, Harris J, Thompson J, Richardson AM, Jones M, Gerhard A, Neary D, Mann DM, Pickering-Brown S (2012) Psychosis, C9ORF72 and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 83(10):1031–1032. doi: 10.1136/jnnp-2012-303032 (10.1136/jnnp-2012-303032) / J Neurol Neurosurg Psychiatry by JS Snowden (2012)
  69. Huey ED, Nagy PL, Rodriguez-Murillo L, Manoochehri M, Goldman J, Lieberman J, Karayiorgou M, Mayeux R (2013) C9ORF72 repeat expansions not detected in a group of patients with schizophrenia. Neurobiol Aging 34(4):1309.e9–1309.e10. doi: 10.1016/j.neurobiolaging.2012.08.011 (10.1016/j.neurobiolaging.2012.08.011) / Neurobiol Aging by ED Huey (2013)
  70. Buchman VL, Cooper-Knock J, Connor-Robson N, Higginbottom A, Kirby J, Razinskaya OD, Ninkina N, Shaw PJ (2013) Simultaneous and independent detection of C9ORF72 alleles with low and high number of GGGGCC repeats using an optimised protocol of Southern blot hybridisation. Mol Neurodegener 8:12. doi: 10.1186/1750-1326-8-12 (10.1186/1750-1326-8-12) / Mol Neurodegener by VL Buchman (2013)
  71. van Blitterswijk M, DeJesus-Hernandez M, Niemantsverdriet E, Murray ME, Heckman MG, Diehl NN, Brown PH, Baker MC, Finch NA, Bauer PO, Serrano G, Beach TG, Josephs KA, Knopman DS, Petersen RC et al (2013) Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study. Lancet Neurol 12(10):978–988. doi: 10.1016/S1474-4422(13)70210-2 (10.1016/S1474-4422(13)70210-2) / Lancet Neurol by M Blitterswijk van (2013)
  72. Dols-Icardo O, Garcia-Redondo A, Rojas-Garcia R, Sanchez-Valle R, Noguera A, Gomez-Tortosa E, Pastor P, Hernandez I, Esteban-Perez J, Suarez-Calvet M, Anton-Aguirre S, Amer G, Ortega-Cubero S, Blesa R, Fortea J et al (2013) Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia. Hum Mol Genet. doi: 10.1093/hmg/ddt460 / Hum Mol Genet by O Dols-Icardo (2013)
  73. Clark RM, De Biase I, Malykhina AP, Al-Mahdawi S, Pook M, Bidichandani SI (2007) The GAA triplet-repeat is unstable in the context of the human FXN locus and displays age-dependent expansions in cerebellum and DRG in a transgenic mouse model. Hum Genet 120(5):633–640. doi: 10.1007/s00439-006-0249-3 (10.1007/s00439-006-0249-3) / Hum Genet by RM Clark (2007)
  74. Dobson-Stone C, Hallupp M, Loy CT, Thompson EM, Haan E, Sue CM, Panegyres PK, Razquin C, Seijo-Martinez M, Rene R, Gascon J, Campdelacreu J, Schmoll B, Volk AE, Brooks WS et al (2013) C9ORF72 repeat expansion in Australian and Spanish frontotemporal dementia patients. PLoS One 8(2):e56899. doi: 10.1371/journal.pone.0056899 (10.1371/journal.pone.0056899) / PLoS One by C Dobson-Stone (2013)
  75. Rutherford NJ, Heckman MG, Dejesus-Hernandez M, Baker MC, Soto-Ortolaza AI, Rayaprolu S, Stewart H, Finger E, Volkening K, Seeley WW, Hatanpaa KJ, Lomen-Hoerth C, Kertesz A, Bigio EH, Lippa C et al (2012) Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype. Neurobiol Aging 33(12):2950.e5–2950.e7. doi: 10.1016/j.neurobiolaging.2012.07.005 (10.1016/j.neurobiolaging.2012.07.005) / Neurobiol Aging by NJ Rutherford (2012)
  76. Chio A, Borghero G, Restagno G, Mora G, Drepper C, Traynor BJ, Sendtner M, Brunetti M, Ossola I, Calvo A, Pugliatti M, Sotgiu MA, Murru MR, Marrosu MG, Marrosu F et al (2012) Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72. Brain 135(Pt 3):784–793. doi: 10.1093/brain/awr366 (10.1093/brain/awr366) / Brain by A Chio (2012)
  77. Radvansky J, Kadasi L (2010) The expanding world of myotonic dystrophies: how can they be detected? Genet Test Mol Biomarkers 14(6):733–741. doi: 10.1089/gtmb 2010.0073 (10.1089/gtmb.2010.0073) / Genet Test Mol Biomarkers by J Radvansky (2010)
  78. Ash PE, Bieniek KF, Gendron TF, Caulfield T, Lin WL, Dejesus-Hernandez M, van Blitterswijk MM, Jansen-West K, Paul JW 3rd, Rademakers R, Boylan KB, Dickson DW, Petrucelli L (2013) Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron 77(4):639–646. doi: 10.1016/j.neuron.2013.02.004 (10.1016/j.neuron.2013.02.004) / Neuron by PE Ash (2013)
  79. Mori K, Weng SM, Arzberger T, May S, Rentzsch K, Kremmer E, Schmid B, Kretzschmar HA, Cruts M, Van Broeckhoven C, Haass C, Edbauer D (2013) The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science 339(6125):1335–1338. doi: 10.1126/science.1232927 (10.1126/science.1232927) / Science by K Mori (2013)
  80. Donnelly CJ, Zhang PW, Pham JT, Heusler AR, Mistry NA, Vidensky S, Daley EL, Poth EM, Hoover B, Fines DM, Maragakis N, Tienari PJ, Petrucelli L, Traynor BJ, Wang J et al (2013) RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron 80(2):415–428. doi: 10.1016/j.neuron.2013.10.015 (10.1016/j.neuron.2013.10.015) / Neuron by CJ Donnelly (2013)
  81. Sareen D, O’Rourke JG, Meera P, Muhammad AK, Grant S, Simpkinson M, Bell S, Carmona S, Ornelas L, Sahabian A, Gendron T, Petrucelli L, Baughn M, Ravits J, Harms MB et al (2013) Targeting RNA foci in iPSC-Derived Motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci Transl Med 5(208):208ra149. doi: 10.1126/scitranslmed.3007529 (10.1126/scitranslmed.3007529) / Sci Transl Med by D Sareen (2013)
  82. Lagier-Tourenne C, Baughn M, Rigo F, Sun S, Liu P, Li HR, Jiang J, Watt AT, Chun S, Katz M, Qiu J, Sun Y, Ling SC, Zhu Q, Polymenidou M et al (2013) Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Proc Natl Acad Sci USA. doi: 10.1073/pnas.1318835110 / Proc Natl Acad Sci USA by C Lagier-Tourenne (2013)
  83. Zu T, Liu Y, Banez-Coronel M, Reid T, Pletnikova O, Lewis J, Miller TM, Harms MB, Falchook AE, Subramony SH, Ostrow LW, Rothstein JD, Troncoso JC, Ranum LP (2013) RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc Natl Acad Sci USA. doi: 10.1073/pnas.1315438110 / Proc Natl Acad Sci USA by T Zu (2013)
  84. Gomez-Tortosa E, Gallego J, Guerrero-Lopez R, Marcos A, Gil-Neciga E, Sainz MJ, Diaz A, Franco-Macias E, Trujillo-Tiebas MJ, Ayuso C, Perez-Perez J (2013) C9ORF72 hexanucleotide expansions of 20-22 repeats are associated with frontotemporal deterioration. Neurology 80(4):366–370. doi: 10.1212/WNL.0b013e31827f08ea (10.1212/WNL.0b013e31827f08ea) / Neurology by E Gomez-Tortosa (2013)
  85. Byrne S, Heverin M, Elamin M, Walsh C, Hardiman O (2013) Intermediate repeat expansion length in C9orf72 may be pathological in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. doi: 10.3109/21678421.2013.838586 / Amyotroph Lateral Scler Frontotemporal Degener by S Byrne (2013)
  86. Cooper-Knock J, Higginbottom A, Connor-Robson N, Bayatti N, Bury JJ, Kirby J, Ninkina N, Buchman VL, Shaw PJ (2013) C9ORF72 transcription in a frontotemporal dementia case with two expanded alleles. Neurology. doi: 10.1212/01.wnl.0000435295.41974.2e / Neurology by J Cooper-Knock (2013)
  87. Xi Z, Zinman L, Moreno D, Schymick J, Liang Y, Sato C, Zheng Y, Ghani M, Dib S, Keith J, Robertson J, Rogaeva E (2013) Hypermethylation of the CpG island near the G4C2 repeat in ALS with a C9orf72 expansion. Am J Hum Genet 92(6):981–989. doi: 10.1016/j.ajhg.2013.04.017 (10.1016/j.ajhg.2013.04.017) / Am J Hum Genet by Z Xi (2013)
  88. Van Deerlin VM, Sleiman PM, Martinez-Lage M, Chen-Plotkin A, Wang LS, Graff-Radford NR, Dickson DW, Rademakers R, Boeve BF, Grossman M, Arnold SE, Mann DM, Pickering-Brown SM, Seelaar H, Heutink P et al (2010) Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet 42(3):234–239. doi: 10.1038/ng.536 (10.1038/ng.536) / Nat Genet by VM Deerlin Van (2010)
  89. Nicholson AM, Finch NA, Wojtas A, Baker MC, Perkerson RB 3rd, Castanedes-Casey M, Rousseau L, Benussi L, Binetti G, Ghidoni R, Hsiung GY, Mackenzie IR, Finger E, Boeve BF, Ertekin-Taner N et al (2013) TMEM106B p. T185S regulates TMEM106B protein levels: implications for frontotemporal dementia. J Neurochem 126(6):781–791. doi: 10.1111/jnc.12329 (10.1111/jnc.12329) / J Neurochem by AM Nicholson (2013)
  90. Gallagher MD, Suh E, Grossman M, Elman L, McCluskey L, Van Swieten JC, Al-Sarraj S, Neumann M, Gelpi E, Ghetti B, Rohrer JD, Halliday G, Van Broeckhoven C, Seilhean D, Shaw PJ et al (2013) TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions. Acta Neuropathol [Epub ahead of print] (10.1007/s00401-013-1239-x)
  91. Levine TP, Daniels RD, Gatta AT, Wong LH, Hayes MJ (2013) The product of C9orf72, a gene strongly implicated in neurodegeneration, is structurally related to DENN Rab-GEFs. Bioinformatics 29(4):499–503. doi: 10.1093/bioinformatics/bts725 (10.1093/bioinformatics/bts725) / Bioinformatics by TP Levine (2013)
  92. van Blitterswijk M, Mullen B, Nicholson AM, Bieniek KF, Heckman MG, Baker MC, Dejesus-Hernandez M, Finch NA, Brown PH, Murray ME, Hsiung GY, Stewart H, Karydas AM, Finger E, Kertesz A et al (2014) TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia. Acta Neuropathol. doi: 10.1007/s00401-013-1240-4 / Acta Neuropathol by M Blitterswijk van (2014)
  93. Tateishi T, Yamasaki R, Tanaka M, Matsushita T, Kikuchi H, Isobe N, Ohyagi Y, Kira J (2010) CSF chemokine alterations related to the clinical course of amyotrophic lateral sclerosis. J Neuroimmunol 222(1–2):76–81. doi: 10.1016/j.jneuroim.2010.03.004 (10.1016/j.jneuroim.2010.03.004) / J Neuroimmunol by T Tateishi (2010)
  94. Kawamata T, Akiyama H, Yamada T, McGeer PL (1992) Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol 140(3):691–707 / Am J Pathol by T Kawamata (1992)
  95. Turner MR, Cagnin A, Turkheimer FE, Miller CC, Shaw CE, Brooks DJ, Leigh PN, Banati RB (2004) Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis 15(3):601–609. doi: 10.1016/j.nbd.2003.12.012 (10.1016/j.nbd.2003.12.012) / Neurobiol Dis by MR Turner (2004)
  96. Henkel JS, Beers DR, Wen S, Rivera AL, Toennis KM, Appel JE, Zhao W, Moore DH, Powell SZ, Appel SH (2013) Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival. EMBO Mol Med 5(1):64–79. doi: 10.1002/emmm.201201544 (10.1002/emmm.201201544) / EMBO Mol Med by JS Henkel (2013)
Dates
Type When
Created 11 years, 6 months ago (Feb. 3, 2014, 9:34 a.m.)
Deposited 6 years ago (Aug. 7, 2019, 4:16 a.m.)
Indexed 1 week ago (Aug. 26, 2025, 2:59 a.m.)
Issued 11 years, 6 months ago (Feb. 4, 2014)
Published 11 years, 6 months ago (Feb. 4, 2014)
Published Online 11 years, 6 months ago (Feb. 4, 2014)
Published Print 11 years, 6 months ago (March 1, 2014)
Funders 0

None

@article{Cooper_Knock_2014, title={The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype}, volume={127}, ISSN={1432-0533}, url={http://dx.doi.org/10.1007/s00401-014-1251-9}, DOI={10.1007/s00401-014-1251-9}, number={3}, journal={Acta Neuropathologica}, publisher={Springer Science and Business Media LLC}, author={Cooper-Knock, Johnathan and Shaw, Pamela J. and Kirby, Janine}, year={2014}, month=feb, pages={333–345} }